3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Neuroendocrine Carcinomas: new trials by email Literature Review of Neuroendocrine Carcinomas trials Research Report on Neuroendocrine Carcinomas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer Folfiri-bevacizumab, Folfiri - Neuroendocrine Carcinomas | Phase 2 | Completed | Hospices Civils de Lyon | 153 | 2017-09-04 | 2025-09-03 |
| Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas Temozolomide - Neuroendocrine Carcinomas | Phase 2 | Completed | National Cancer Institute, Naples | 25 | 2017-01-29 | 2020-10-26 |
| Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients TLC 388 - Neuroendocrine Carcinomas | Phase 2 | Completed | National Health Research Institutes, Taiwan | 23 | 2015-07-04 | 2019-04-03 |
Adenocarcinoma (3) · Carcinoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3)
IFL protocol (1) · TLC 388 (1) · Temozolomide (1)
Hospices Civils de Lyon (1) · National Cancer Institute, Naples (1) · National Health Research Institutes, Taiwan (1)
France (1) · Italy (1) · Taiwan (1)
Cheng-Chung Wu, MS (1) · Chia-Jui Yen, MD., PhD (1) · Chiun Hsu, MD., PhD (1) · Hui-Jen Tsai, MD., PhD (1) · Jen-Shi Chen, MD (1) · Ming-Huang Chen, MD., PhD (1) · Ta-Chih Liu, MD., PhD (1) · Yee Chao, MD., PhD (1) · Yen-Yang Chen, MD (1)
PMID 31852810, PMID 36739879, PMID 38615472
2016 (1)